Delivery Order SPE2DB20D1100-SPE2DB25FE6E8
- Not listed
- The Defense Logistics Agency awarded a $10,858.52 delivery order to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 ml auto-injector pharmaceutical product on July 25, 2025, with final delivery scheduled for July 28, 2025. This firm fixed-price, non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a $10,863.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of BIMZELX 160 mg/ml autoinjectors. The contract, which will be performed at the company's corporate office location in Conshohocken, Pennsylvania, represents a non-competitive delivery order without set-aside designation. This award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $11,394.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injector product, with an ultimate completion date of August 6, 2025. This competitively awarded contract, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a $51,713.58 delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with completion scheduled for September 11, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $9,783.88 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjector on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The contract represents a single shipment of this specialty...
- The Defense Logistics Agency awarded a $69,112.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with an ultimate completion date of August 5, 2025. This competitive award, which was not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/mL auto-injectors, a specialty pharmaceutical product, with a ceiling value of $26,727.10. This firm fixed-price delivery order, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive set-aside award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $65,888.65 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of BIMZELX 320 MG/2 ML auto-injector medications. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. BIMZELX is a specialty pharmaceutical product used in the treatment of immunological conditions, reflecting the company's continued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of BIMZELX 320 mg/2 ml auto-injector units valued at $9,855.21 with completion by August 1, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $45,373.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with a completion date of July 22, 2025. This non-set-aside contract represents a direct procurement of a specialized pharmaceutical product to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6E8Delivery Order
The Defense Logistics Agency awarded a $23,855.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 mL auto-injector pharmaceutical product on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company holds a comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026, which enables the supply of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. This particular delivery order for BIMZELX, a specialty pharmaceutical product, exemplifies the breadth of therapeutic categories the vendor provides under its prime contract vehicle with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 9/11/25 |